Publicado 6 números por año
ISSN Imprimir: 1040-8401
ISSN En Línea: 2162-6472
Indexed in
Dendritic Cell-Based Immunotherapy of Prostate Cancer
SINOPSIS
The immunotherapy of cancer, based on eliciting or enhancing the body’s own capacity to mount an effective antitumor response, has produced encouraging early results in the areas of melanoma and renal-cell carcinoma. Such treatments utilizing dendritic cells (DC), immune cells that are excellent antigen presenters, are especially promising. We performed a phase I clinical trial assessing the administration of autologous DC pulsed with HLA-A0201 -specific prostate-specific membrane antigen (PSMA) for the treatment of 51 men with hormone-refractory prostate cancer. Participants were divided into five groups receiving four or five infusions of peptides alone (PSM-P1 or PSM-P2; group 1 and 2, respectively), autologous DC (group 3), or DC pulsed with PSM-P1 or P2 (group 4 and 5, respectively). No significant toxicity was observed. Immune reactivity against PSM-P2 was detected in HLA-A2+ patients infused with DC pulsed with PSM-P1 or -P2 (group 4 and 5). An average decrease in PSA was observed only in group 5. Seven partial responders were identified based on NPCP criteria + PSA. The excellent tolerance of this treatment approach, as well as the enhanced cellular responses, decreased PSA levels, and partial clinical responses in some patients suggests that it holds great potential in prostate cancer therapy.
-
Lee Wei-Chen, Wang Hui-Chuan, Hung Chien-Fu, Huang Pei-Fang, Lia Chen-Rong, Chen Miin-Fu, Vaccination of Advanced Hepatocellular Carcinoma Patients with Tumor Lysate-Pulsed Dendritic Cells, Journal of Immunotherapy, 28, 5, 2005. Crossref
-
Siemens D. Robert, Ratliff Timothy L., Are Vaccinations for Prostate Cancer Realistic?, in Prostate Cancer, 2003. Crossref
-
BLANCO PATRICK, PALUCKA A. KAROLINA, BANCHEREAU JACQUES, Introduction to Dendritic Cells, in Gene Therapy of Cancer, 2002. Crossref
-
Davis Ian D, An overview of cancer immunotherapy, Immunology and Cell Biology, 78, 3, 2000. Crossref
-
Dietz Allan B., Bulur Peggy A., Erickson Michele R., Wettstein Peter J., Litzow Mark R., Wyatt William A., Dewald Gordon W., Tefferi Ayelew, Pankratz V. Shane, Vuk-Pavlovic Stanimir, Optimizing Preparation of Normal Dendritic Cells andbcr-abl+Mature Dendritic Cells Derived from Immunomagnetically Purified CD14+Cells, Journal of Hematotherapy & Stem Cell Research, 9, 1, 2000. Crossref
-
Burch Patrick A., Croghan Gary A., Gastineau Dennis A., Jones Lori A., Kaur Judith S., Kylstra Jelle W., Richardson Ronald L., Valone Frank H., Vuk-Pavlović Stanimir, Immunotherapy (APC8015, Provenge®) targeting prostatic acid phosphatase can induce durable remission of metastatic androgen-independent prostate cancer: A phase 2 trial, The Prostate, 60, 3, 2004. Crossref
-
McKenzie Ian FC, Apostolopoulos Vasso, Plebanski Magdalena, Pietersz Geoffrey A, Loveland Bruce E, Aspects of cancer immunotherapy, Immunology & Cell Biology, 81, 1, 2003. Crossref
-
Granziero Luisa, Krajewski Stanislaw, Farness Peggy, Yuan Lunli, Courtney Michele K., Jackson Michael R., Peterson Per A., Vitiello Antonella, Adoptive immunotherapy prevents prostate cancer in a transgenic animal model, European Journal of Immunology, 29, 4, 1999. Crossref
-
Iwase Shigeru, Tsujimura Kunio, Matsudaira Yasue, Ozeki Satoshi, Onozaki Kikuo, Obata Yuichi, Takahashi Toshitada, Comparison of Anti-Tumor Responses against TL Positive Lymphoma Induced by Skin Grafting and Dendritic Cell Immunization, Microbiology and Immunology, 44, 7, 2000. Crossref
-
Gao Xiang, Honn Kenneth V., Chapter 4 Tumor markers for prostate cancer, in The Oncobiology of the Prostate, 3, 1999. Crossref
-
Balkow Sandra, Loser Karin, Krummen Mathias, Higuchi Tetsuya, Rothoeft Tobias, Apelt Jenny, Tuettenberg Andrea, Weishaupt Carsten, Beissert Stefan, Grabbe Stephan, Dendritic cell activation by combined exposure to anti-CD40 plus interleukin (IL)-12 and IL-18 efficiently stimulates anti-tumor immunity, Experimental Dermatology, 18, 1, 2009. Crossref
-
Yamaguchi Shinjiro, Tatsumi Tomohide, Takehara Tetsuo, Sakamori Ryotaro, Uemura Akio, Mizushima Tsunekazu, Ohkawa Kazuyoshi, Storkus Walter J., Hayashi Norio, Immunotherapy of murine colon cancer using receptor tyrosine kinase EphA2-derived peptide-pulsed dendritic cell vaccines, Cancer, 110, 7, 2007. Crossref
-
Cai Quan, Kublo Lyubov, Cumberland Rachel, Gooding William, Baar Joseph, Optimized Systemic Dosing with CpG DNA Enhances Dendritic Cell-Mediated Rejection of a Poorly Immunogenic Mammary Tumor in BALB/c Mice, Clinical and Translational Science, 2009. Crossref
-
Di Nicola Massimo, Carlo-Stella Carmelo, Anichini Andrea, Mortarini Roberta, Guidetti Anna, Tragni Gabrina, Gallino Francesco, Del Vecchio Michele, Ravagnani Fernando, Morelli Daniele, Chaplin Paul, Arndtz Nathaly, Sutter Gerd, Drexler Ingo, Parmiani Giorgio, Cascinelli Natale, Gianni Alessandro M., Immunization of Patients with Malignant Melanoma with Autologous CD34+Cell-Derived Dendritic Cells TransducedEx Vivowith a Recombinant Replication-Deficient Vaccinia Vector Encoding the Human Tyrosinase Gene: A Phase I Trial, Human Gene Therapy, 14, 14, 2003. Crossref
-
Salgaller Michael L, Prostate cancer immunotherapy at the dawn of the new millennium, Expert Opinion on Investigational Drugs, 9, 6, 2000. Crossref
-
Jones Lori A, Salgaller Michael L, Immunologic approaches to antigen discovery for cancer vaccines, Expert Opinion on Investigational Drugs, 9, 3, 2000. Crossref
-
Tatsumi Tomohide, Takehara Tetsuo, Yamaguchi Shinjiro, Sasakawa Akira, Sakamori Ryotaro, Ohkawa Kazuyoshi, Kohga Keisuke, Uemura Akio, Hayashi Norio, Intrahepatic delivery of α-galactosylceramide-pulsed dendritic cells suppresses liver tumor, Hepatology, 45, 1, 2007. Crossref
-
Cai Quan, Kublo Lyubov, Cumberland Rachel, Gooding William, Baar Joseph, Optimized Systemic Dosing with CpG DNA Enhances Dendritic Cell-Mediated Rejection of a Poorly Immunogenic Mammary Tumor in BALB/c Mice, Clinical and Translational Science, 2, 1, 2009. Crossref
-
Lathers Deanne M.R., Clark Joseph I., Achille Nicholas J., Young M.Rita I., Phase IB study of 25-hydroxyvitamin D3 treatment to diminish suppressor cells in head and neck cancer patients, Human Immunology, 62, 11, 2001. Crossref
-
Berlyn Kathleen A., Schultes Birgit, Leveugle Beatrice, Noujaim Antoine A., Alexander Richard B., Mann Dean L., Generation of CD4+ and CD8+ T Lymphocyte Responses by Dendritic Cells Armed with PSA/Anti-PSA (Antigen/Antibody) Complexes, Clinical Immunology, 101, 3, 2001. Crossref
-
Scott-Taylor T.H., Pettengell R., Clarke I., Stuhler G., La Barthe M.C., Walden P., Dalgleish A.G., Human tumour and dendritic cell hybrids generated by electrofusion: potential for cancer vaccines, Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease, 1500, 3, 2000. Crossref
-
Oehler Leopold, Berer Andrea, Keil Felix, Weinländer Georg, König Margit, Haas Oskar A., Lechner Klaus, Geissler Klaus, Generation of Dendritic Cells from Human Chronic Myelomonocytic Leukemia Cells in Fetal Calf Serum-Free Medium, Leukemia & Lymphoma, 38, 5-6, 2000. Crossref
-
Ferrer Fernando A., Rodriguez Ronald, PROSTATE CANCER GENE THERAPY, Hematology/Oncology Clinics of North America, 15, 3, 2001. Crossref
-
Nouri-Shirazi Mahyar, Banchereau Jacques, Fay Joseph, Palucka Karolina, Dendritic cell based tumor vaccines, Immunology Letters, 74, 1, 2000. Crossref
-
Bremers A.J.A, Kuppen P.J.K, Parmiani G, Tumour immunotherapy: the adjuvant treatment of the21st century?, European Journal of Surgical Oncology (EJSO), 26, 4, 2000. Crossref
-
Bremers Andreas J.A, Parmiani Giorgio, Immunology and immunotherapy of human cancer: present concepts and clinical developments, Critical Reviews in Oncology/Hematology, 34, 1, 2000. Crossref
-
Rodriguez Ronald, Simons Jonathan W, Urologic applications of gene therapy, Urology, 54, 3, 1999. Crossref
-
Mitchell Duane A., Sampson John H., Toward effective immunotherapy for the treatment of malignant brain tumors, Neurotherapeutics, 6, 3, 2009. Crossref
-
Broghammer Elizabeth L., Ratliff Timothy L., Immunotherapy of urologic tumors, Urologic Oncology: Seminars and Original Investigations, 7, 2, 2002. Crossref
-
Lubaroff David M., Karan Dev, CpG oligonucleotide as an adjuvant for the treatment of prostate cancer, Advanced Drug Delivery Reviews, 61, 3, 2009. Crossref
-
Lowenfeld Lea, Zaheer Salman, Oechsle Crystal, Fracol Megan, Datta Jashodeep, Xu Shuwen, Fitzpatrick Elizabeth, Roses Robert E., Fisher Carla S., McDonald Elizabeth S., Zhang Paul J., DeMichele Angela, Mick Rosemarie, Koski Gary K., Czerniecki Brian J., Addition of anti-estrogen therapy to anti-HER2 dendritic cell vaccination improves regional nodal immune response and pathologic complete response rate in patients with ERpos/HER2pos early breast cancer, OncoImmunology, 6, 9, 2017. Crossref
-
Goxe B., Latour N., Chokri M., Abastado J. P., Salcedo M., Simplified Method to Generate Large Quantities of Dendritic Cells Suitable for Clinical Applications, Immunological Investigations, 29, 3, 2000. Crossref
-
Bedrosian Isabelle, Roros James G., Xu Shuwen, Nguyen Hung Q., Engels Friederike, Faries Mark B., Koski Gary K., Cohen Peter A., Czerniecki Brian J., Granulocyte-Macrophage Colony-Stimulating Factor, Interleukin-2, and Interleukin-12 Synergize With Calcium Ionophore to Enhance Dendritic Cell Function, Journal of Immunotherapy, 23, 3, 2000. Crossref
-
Hori Shin-ichi, Heike Yuji, Takei Masao, Maruyama Midori, Inoue Yoshiko, Lee Je-Jung, Kim Hyeoung-Joon, Harada Yukie, Kawai Hiroyuki, Shimosaka Akihiro, Kami Masahiro, Tanosaki MD Ryuji, Wakasugi Hiro, Saito Shigeru, Takaue Yoichi, Kakizoe Tadao, Freeze-Thawing Procedures Have No Influence on the Phenotypic and Functional Development of Dendritic Cells Generated from Peripheral Blood CD14+ Monocytes, Journal of Immunotherapy, 27, 1, 2004. Crossref
-
Zhang Jin-Kun, Antitumor activities of human dendritic cells derived from peripheral and cord blood, World Journal of Gastroenterology, 8, 1, 2002. Crossref
-
Shimamura Hiromune, Cumberland Rachel, Hiroishi Kazumasa, Watkins Simon C., Lotze Michael T., Baar Joseph, Murine Dendritic Cell-Induced Tumor Apoptosis is Partially Mediated by Nitric Oxide, Journal of Immunotherapy, 25, 3, 2002. Crossref
-
Zöller Margot, Immunotherapy of Cancer by Active Vaccination: Does Allogeneic Bone Marrow Transplantation after Non-Myeloablative Conditioning Provide a New Option?, Technology in Cancer Research & Treatment, 2, 3, 2003. Crossref
-
Stevanovic Stefan, Identification of tumour-associated t-cell epitopes for vaccine development, Nature Reviews Cancer, 2, 7, 2002. Crossref
-
Di Nicola Massimo, Gianni A Massimo, Dendritic Cells, Tumori Journal, 1, 6_suppl1, 2002. Crossref
-
Joshi Bishnu P., Hardie Joseph, Farkas Michelle E., Harnessing Biology to Deliver Therapeutic and Imaging Entities via Cell-Based Methods, Chemistry - A European Journal, 24, 35, 2018. Crossref
-
Arrighi Jean-François, Hauser Conrad, Chapuis Bernard, Zubler Rudolf H., Kindler Vincent, Long-Term Culture of Human CD34+ Progenitors With FLT3-Ligand, Thrombopoietin, and Stem Cell Factor Induces Extensive Amplification of a CD34−CD14− and a CD34−CD14+ Dendritic Cell Precursor, Blood, 93, 7, 1999. Crossref
-
Weigel Brenda J., Nath Narender, Taylor Patricia A., Panoskaltsis-Mortari Angela, Chen Wei, Krieg Arthur M., Brasel Kenneth, Blazar Bruce R., Comparative analysis of murine marrow–derived dendritic cells generated by Flt3L or GM-CSF/IL-4 and matured with immune stimulatory agents on the in vivo induction of antileukemia responses, Blood, 100, 12, 2002. Crossref
-
Arrighi Jean-François, Hauser Conrad, Chapuis Bernard, Zubler Rudolf H., Kindler Vincent, Long-Term Culture of Human CD34+ Progenitors With FLT3-Ligand, Thrombopoietin, and Stem Cell Factor Induces Extensive Amplification of a CD34−CD14− and a CD34−CD14+ Dendritic Cell Precursor, Blood, 93, 7, 1999. Crossref
-
Dhodapkar Madhav V., Dendritic Cell Vaccines, in Handbook of Cancer Vaccines, 2004. Crossref
-
Schadendorf D., Nestle F. O., Autologous Dendritic Cells for Treatment of Advanced Cancer — An Update, in Minimal Residual Disease in Melanoma, 158, 2001. Crossref
-
Abraham Samuel J. K., Terunuma Hiroshi, Dedeepiya Vidyasagar Devaprasad, Premkumar Sumana, Preethy Senthilkumar, An Overview of Treatment for Cervical Cancer with Emphasis on Immune Cell-Based Therapies, in International Manual of Oncology Practice, 2015. Crossref
-
Pawlowska Anna B., Hashino Satoshi, McKenna Hilary, Weigel Brenda J., Taylor Patricia A., Blazar Bruce R., In vitro tumor-pulsed or in vivo Flt3 ligand–generated dendritic cells provide protection against acute myelogenous leukemia in nontransplanted or syngeneic bone marrow–transplanted mice, Blood, 97, 5, 2001. Crossref
-
Lu Qianglan, Qi Sun, Li Peishan, Yang Lifang, Yang Shan, Wang Yidan, Cheng Yu, Song Yilin, Wang Siyu, Tan Fengping, Li Nan, Photothermally activatable PDA immune nanomedicine combined with PD-L1 checkpoint blockade for antimetastatic cancer photoimmunotherapy, Journal of Materials Chemistry B, 7, 15, 2019. Crossref
-
Matzku Siegfried, Z??ller Margot, Specific Immunotherapy of Cancer in Elderly Patients, Drugs & Aging, 18, 9, 2001. Crossref
-
Pirtskhalaishvili Georgi, Shurin Galina V., Gambotto Andrea, Esche Clemens, Wahl Madeline, Yurkovetsky Zoya R., Robbins Paul D., Shurin Michael R., Transduction of Dendritic Cells with Bcl-xLIncreases Their Resistance to Prostate Cancer-Induced Apoptosis and Antitumor Effect in Mice, The Journal of Immunology, 165, 4, 2000. Crossref
-
VAN ZANTEN J., HOSPERS G. A. P., HARMSEN M. C., THE T. H., MULDER N. H., DE LEIJ L. F. M. H., Dendritic Cells Present an Intracellular Viral Antigen Derived from Apoptotic Cells and Induce a T-Cell Response, Scandinavian Journal of Immunology, 56, 3, 2002. Crossref
-
Zhu Yi, Goh Cynthia, Shrestha Annie, Biomaterial Properties Modulating Bone Regeneration, Macromolecular Bioscience, 21, 4, 2021. Crossref
-
Baar Joseph, Clinical Applications of Dendritic Cell Cancer Vaccines, The Oncologist, 4, 2, 1999. Crossref
-
Lowenfeld Lea, Mick Rosemarie, Datta Jashodeep, Xu Shuwen, Fitzpatrick Elizabeth, Fisher Carla S., Fox Kevin R., DeMichele Angela, Zhang Paul J., Weinstein Susan P., Roses Robert E., Czerniecki Brian J., Dendritic Cell Vaccination Enhances Immune Responses and Induces Regression of HER2pos DCIS Independent of Route: Results of Randomized Selection Design Trial, Clinical Cancer Research, 23, 12, 2017. Crossref
-
Mercader Maria, Bodner Barbara K., Moser Micheal T., Kwon Pamela S., Park Eugene S. Y., Manecke Ryan G., Ellis Thomas M., Wojcik Eva M., Yang Damu, Flanigan Robert C., Waters W. Bedford, Kast W. Martin, Kwon Eugene D., T cell infiltration of the prostate induced by androgen withdrawal in patients with prostate cancer, Proceedings of the National Academy of Sciences, 98, 25, 2001. Crossref
-
Li RuYan, Zheng QingHua, Deng QiuPing, Wang Yi, Yang HaoDing, Shen Jian, Liu YingHui, Zhou JiaHong, A Dual Functional Drug Delivery System that Combines Photothermal Therapy and Immunotherapy to Treat Tumors, Molecular Pharmaceutics, 19, 5, 2022. Crossref
-
Tatsumi T, Takehara T, Yamaguchi S, Sasakawa A, Miyagi T, Jinushi M, Sakamori R, Kohga K, Uemura A, Ohkawa K, Storkus W J, Hayashi N, Injection of IL-12 gene-transduced dendritic cells into mouse liver tumor lesions activates both innate and acquired immunity, Gene Therapy, 14, 11, 2007. Crossref
-
Butch Anthony W, Kelly Kathleen A, Munshi Nikhil C, Dendritic cells derived from multiple myeloma patients efficiently internalize different classes of myeloma protein, Experimental Hematology, 29, 1, 2001. Crossref
-
Ferrer Fernando A., Rodriguez Ronald, Gene therapy for urologic cancer, Current Urology Reports, 3, 1, 2002. Crossref
-
Barrou Benoît, Benoît Gérard, Ouldkaci Mahmoud, Cussenot Olivier, Salcedo Margarita, Agrawal Sudhanshu, Massicard Séverine, Bercovici Nadège, Ericson Mats L., Thiounn Nicolas, Vaccination of prostatectomized prostate cancer patients in biochemical relapse, with autologous dendritic cells pulsed with recombinant human PSA, Cancer Immunology, Immunotherapy, 53, 5, 2004. Crossref
-
Prabakaran Indira, Menon Chandrakala, Xu Shuwen, Gómez-Yafal Alicia, Czerniecki Brian J., Fraker Douglas L., Mature CD83+ dendritic cells infected with recombinant gp 100 vaccinia virus stimulate potent antimelanoma T cells, Annals of Surgical Oncology, 9, 4, 2002. Crossref
-
Chang David H., Dhodapkar Madhav V., Dendritic Cells and Immunotherapy for Cancer, International Journal of Hematology, 77, 5, 2003. Crossref